Skip to content

Amgen AMGN PP&E (Net)

PP&E (Net) at other companies

Eli Lilly logo
Eli LillyLLY
$26.54B+43.7%
Pfizer logo
PfizerPFE
$19.4B+5.8%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$5.46B
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$318K+100%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$203.1M+13.5%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$1.28M-26.5%

Segments

By geography

See full
ROW$1.45B+19.7%

Other financials

Income statement

See full
Revenue$8.6B+5.8%
Gross profit$5.9B+13.4%
Operating income$2.7B+126%
Net income$1.8B+5.1%
EPS (diluted)$3.34+4.4%

Balance sheet

See full
Cash & equivalents$559.0M+10.0%
Total debt$57.3B-0.1%
Total equity$9.2B+48.1%
Total assets$92.5B+3.5%

Cash flow

See full
Operating cash flow$2.2B+57.4%
CapEx$712.0M+73.2%
Free cash flow$1.5B+50.7%

Valuation

See full
Market cap$212.16B+30.0%
Enterprise value$268.92B+22.9%
P/E27.2×+2.5×
P/S5.7×+1.0×

Profitability

See full
Gross margin68.3%+5.3pp
Operating margin28.4%+6.6pp
Net margin21%+3.6pp
FCF margin23.1%-8.9pp

Returns & leverage

See full
Return on equity101.3%-4.4pp
Debt / equity6.2×-3.0×
Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amgen's PP&E (net)?
Amgen (AMGN) reported PP&E (net) of $8.22B in Q1 2026.
How has Amgen's PP&E (net) changed year-over-year?
Amgen's PP&E (net) increased by 23.0% year-over-year, from $6.68B to $8.22B.
What is the long-term trend for Amgen's PP&E (net)?
Over 5 years (2020 to 2025), Amgen's PP&E (net) has grown at a 10.1% compound annual growth rate (CAGR), from $4.89B to $7.91B.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.